• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《影响髓母细胞瘤切除术范围的临床重要性:系统综述》

The clinical importance of medulloblastoma extent of resection: a systematic review.

机构信息

Department of Neurosurgery, Duke University, Durham, NC, USA.

Preston Robert Tisch Brain Tumor Center, Duke University, Durham, NC, USA.

出版信息

J Neurooncol. 2018 Sep;139(3):523-539. doi: 10.1007/s11060-018-2906-5. Epub 2018 May 23.

DOI:10.1007/s11060-018-2906-5
PMID:29796724
Abstract

BACKGROUND

Although the majority of current medulloblastoma adjuvant therapy protocols treat patients with ≥ 1.5 cm residual tumor as high risk with increased craniospinal irradiation, the true prognostic significance of extent of resection (EOR) in medulloblastoma is unknown.

OBJECTIVES

We sought to synthesize the body of literature on EOR and survival to determine if a definitive association exists.

DATA SOURCES/ELIGIBILITY CRITERIA: A PubMed search was conducted for the terms "medulloblastoma" combined with "extent of resection," "overall survival," "progression free survival," "gross total resection," "near total resection," "partial resection," or "subtotal resection." Studies that performed a statistical analysis of EOR and survival were included.

RESULTS

Sixteen articles including 1489 patients found a statistically significant association between EOR and survival, 20 articles including 2335 patients did not find a significant association between EOR and survival, and 14 articles including 2950 patients had mixed results. The three articles that accounted for molecular subgroup found varying associations between EOR and progression free survival, while no association was found between EOR and overall survival.

LIMITATIONS

This review is limited by inconsistent definitions of EOR, the retrospective nature of the articles analyzed, and infrequent use of multivariate statistical analyses.

CONCLUSIONS

The prognostic importance of EOR for medulloblastoma is unclear and warrants re-evaluation, particularly in the context of molecular subgrouping.

摘要

背景

尽管目前大多数髓母细胞瘤辅助治疗方案将有≥1.5cm 残余肿瘤的患者视为高危患者,增加颅脊髓照射,但肿瘤切除范围(EOR)在髓母细胞瘤中的真正预后意义尚不清楚。

目的

我们试图综合 EOR 和生存的文献,以确定两者之间是否存在明确的关联。

资料来源/入选标准:在 PubMed 上使用“髓母细胞瘤”与“切除范围”、“总生存”、“无进展生存”、“大体全切除”、“近全切除”、“部分切除”或“次全切除”等术语进行搜索。纳入对 EOR 和生存进行统计学分析的研究。

结果

16 篇文章(包括 1489 例患者)发现 EOR 与生存之间存在统计学显著关联,20 篇文章(包括 2335 例患者)未发现 EOR 与生存之间存在显著关联,14 篇文章(包括 2950 例患者)结果混杂。有 3 篇文章对分子亚组进行了分析,发现 EOR 与无进展生存之间存在不同的关联,而 EOR 与总生存之间没有关联。

局限性

本综述受到 EOR 定义不一致、分析文章的回顾性以及很少使用多变量统计分析的限制。

结论

EOR 对髓母细胞瘤的预后意义尚不清楚,需要重新评估,特别是在分子亚组的背景下。

相似文献

1
The clinical importance of medulloblastoma extent of resection: a systematic review.《影响髓母细胞瘤切除术范围的临床重要性:系统综述》
J Neurooncol. 2018 Sep;139(3):523-539. doi: 10.1007/s11060-018-2906-5. Epub 2018 May 23.
2
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
3
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
6
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
7
Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review.术中 5-ALA 荧光引导切除高级别胶质瘤可提高切除程度,改善预后:系统评价。
J Neurooncol. 2022 Jan;156(2):233-256. doi: 10.1007/s11060-021-03901-9. Epub 2022 Jan 6.
8
Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma.嵌合抗原受体 (CAR) T 细胞疗法治疗复发或难治性弥漫性大 B 细胞淋巴瘤患者。
Cochrane Database Syst Rev. 2021 Sep 13;9(9):CD013365. doi: 10.1002/14651858.CD013365.pub2.
9
Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.治疗胶质母细胞瘤进展或复发的选择:网络荟萃分析。
Cochrane Database Syst Rev. 2021 May 4;5(1):CD013579. doi: 10.1002/14651858.CD013579.pub2.
10
Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines.右雷佐生预防或减少接受蒽环类抗生素治疗的癌症成人和儿童的心脏毒性。
Cochrane Database Syst Rev. 2022 Sep 27;9(9):CD014638. doi: 10.1002/14651858.CD014638.pub2.

引用本文的文献

1
Advancing medulloblastoma therapy: strategies and survival insights.髓母细胞瘤治疗进展:策略与生存见解
Clin Exp Med. 2025 Apr 16;25(1):119. doi: 10.1007/s10238-025-01648-5.
2
Development of a simple prediction model for tracheostomy requirement after surgical resection of medulloblastoma in children.儿童髓母细胞瘤手术切除后气管切开需求的简单预测模型的开发。
BMC Res Notes. 2025 Jan 10;18(1):8. doi: 10.1186/s13104-025-07085-7.
3
Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent magnetic resonance imaging lesions after first-line treatment.

本文引用的文献

1
Intertumoral Heterogeneity within Medulloblastoma Subgroups.髓母细胞瘤亚组内的肿瘤间异质性。
Cancer Cell. 2017 Jun 12;31(6):737-754.e6. doi: 10.1016/j.ccell.2017.05.005.
2
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.儿童髓母细胞瘤临床分类及预后预测的新型分子亚组:一项队列研究
Lancet Oncol. 2017 Jul;18(7):958-971. doi: 10.1016/S1470-2045(17)30243-7. Epub 2017 May 22.
3
The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival.
一线治疗后存在 MRI 残留病灶的儿童髓母细胞瘤中,以治疗反应作为替代指标预测疾病进展风险。
Neuro Oncol. 2024 Sep 5;26(9):1712-1722. doi: 10.1093/neuonc/noae071.
4
Primary central nervous system tumors survival in children in ten Colombian cities: a VIGICANCER report.十所哥伦比亚城市儿童原发性中枢神经系统肿瘤的生存率:一份VIGICANCER报告
Front Oncol. 2024 Feb 27;13:1326788. doi: 10.3389/fonc.2023.1326788. eCollection 2023.
5
The clinical significance of sub-total surgical resection in childhood medulloblastoma: a multi-cohort analysis of 1100 patients.儿童髓母细胞瘤次全手术切除的临床意义:1100例患者的多队列分析
EClinicalMedicine. 2024 Feb 14;69:102469. doi: 10.1016/j.eclinm.2024.102469. eCollection 2024 Mar.
6
Atypical teratoid rhabdoid tumor in a lower middle‑income country: Challenges to cure.低收入中等国家的非典型畸胎样横纹肌样瘤:治愈面临的挑战。
Oncol Lett. 2024 Jan 30;27(3):129. doi: 10.3892/ol.2024.14263. eCollection 2024 Mar.
7
Evolution of neurosurgical advances and nuances in medulloblastoma therapy.神经外科进展的演变和髓母细胞瘤治疗的细微差别。
Childs Nerv Syst. 2024 Apr;40(4):1031-1044. doi: 10.1007/s00381-023-06239-x. Epub 2023 Dec 19.
8
Recent Advances in Pediatric Medulloblastoma.小儿髓母细胞瘤的最新进展。
Curr Neurol Neurosci Rep. 2023 Dec;23(12):841-848. doi: 10.1007/s11910-023-01316-9. Epub 2023 Nov 9.
9
A scoring system categorizing risk factors to evaluate the need for ventriculoperitoneal shunt in pediatric patients after brain tumor resection.一种对风险因素进行分类的评分系统,用于评估小儿脑肿瘤切除术后患者行脑室腹腔分流术的必要性。
Front Oncol. 2023 Oct 17;13:1248553. doi: 10.3389/fonc.2023.1248553. eCollection 2023.
10
Neurosurgical treatment of pediatric brain tumors - results from a single center multidisciplinary setup.神经外科治疗小儿脑肿瘤 - 来自单中心多学科设置的结果。
Childs Nerv Syst. 2024 Feb;40(2):381-393. doi: 10.1007/s00381-023-06123-8. Epub 2023 Sep 21.
血管生成在 3 组髓母细胞瘤发病机制和生存中的作用。
Neuro Oncol. 2017 Sep 1;19(9):1217-1227. doi: 10.1093/neuonc/nox033.
4
A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A report from the Children's Oncology Group.一项针对新诊断的高危髓母细胞瘤儿童的II期可行性研究:口服依托泊苷与放疗同时进行,随后进行剂量密集辅助化疗(方案POG 9631):来自儿童肿瘤学组的报告
Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26373. Epub 2016 Dec 21.
5
Adjuvant chemotherapy and overall survival in adult medulloblastoma.成人髓母细胞瘤的辅助化疗与总生存期
Neuro Oncol. 2017 Feb 1;19(2):259-269. doi: 10.1093/neuonc/now150.
6
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.分子时代儿童髓母细胞瘤的风险分层:当前共识
Acta Neuropathol. 2016 Jun;131(6):821-31. doi: 10.1007/s00401-016-1569-6. Epub 2016 Apr 4.
7
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis.在考虑分子亚组因素后髓母细胞瘤切除范围的预后价值:一项回顾性综合临床与分子分析
Lancet Oncol. 2016 Apr;17(4):484-495. doi: 10.1016/S1470-2045(15)00581-1. Epub 2016 Mar 12.
8
Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.质子放射疗法治疗儿童髓母细胞瘤的长期毒性作用:一项 2 期单臂研究。
Lancet Oncol. 2016 Mar;17(3):287-298. doi: 10.1016/S1470-2045(15)00167-9. Epub 2016 Jan 30.
9
Clinical characteristics and abandonment and outcome of treatment in 67 Chinese children with medulloblastoma.67例中国儿童髓母细胞瘤的临床特征、治疗放弃情况及治疗结果
J Neurosurg Pediatr. 2016 Jan;17(1):49-56. doi: 10.3171/2015.5.PEDS1573. Epub 2015 Oct 9.
10
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program.成人髓母细胞瘤的放射治疗:单机构长期结果。预后因素综述及我们为何需要多机构合作项目。
Rep Pract Oncol Radiother. 2015 Jul-Aug;20(4):284-91. doi: 10.1016/j.rpor.2015.03.003. Epub 2015 Apr 8.